Timothy WilliamsSenior Vice President, General Counsel and Secretary at Vanda PharmaceuticalsExecutive
CorporateVanda Pharma's NEREUS Becomes First New Motion Sickness Drug in 40 Years — Shares Surge 18%Dec 31, 2025